Regulation of inflammatory vascular damage

Journal of Pathology

Volumn 190, Issue 3, 2000, Pages 343-348

  Lentsch, Alex B ^a   Ward, Peter A ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Endothelial cells; Inflammation; Neutrophils; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; GENE ACTIVATION; GENE EXPRESSION REGULATION; INFLAMMATION; MEDIATOR RELEASE; NEUTROPHIL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VASCULAR ENDOTHELIUM;

ACUTE-PHASE REACTION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MICROCIRCULATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; TRANSCRIPTION FACTORS; VASCULITIS;

EID: 0034050430     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:3<343::AID-PATH522>3.0.CO;2-M     Document Type: Review

References (39)

1. Varani J, Dame MK, Gibbs DF, et al. Human umbilical vein endothelial cell killing by activated neutrophils. Loss of sensitivity to injury is accompanied by decreased iron content during in vitro culture and is restored with exogenous iron. Lab Invest 1992; 66: 708-714.
2. Fujita H, Morita I, Murota S. Involvement of adhesion molecules (CD11a ICAM-1) in vascular endothelial cell injury elicited by PMA-stimulated neutrophils. Biochem Biophys Res Commun 1991; 177: 664-672.
3. Phan SH, Gannon DE, Ward PA, Karmiol S. Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of a role for elastase. Am J Respir Cell Mol Biol 1992; 6: 270-278.
4. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
5. Kubes P, Suzuki M, Granger DN. Nitric oxide. An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
6. Kausalya S, Nath J. Interactive role of nitric oxide and superoxide anion in neutrophil-mediated endothelial cell injury. J Leuk Biol 1998; 654: 185-191.
7. Murphy HS, Bakopoulos N, Dame MK, Varani J, Ward PA. Heterogeneity of vascular endothelial cells: differences in susceptibility to neutrophil-mediated injury. Microvasc Res 1998; 56: 203-211.
8. Murphy HS, Warner RL, Bakopoulos N, Dame MK, Varani J, Ward PA. Endothelial cell determinants of susceptibility to neutrophil-mediated killing. Shock 1999; 12: 111-117.
9. Schuger L, Varani J, Marks RM, Kunkel SL, Johnson KJ, Ward PA. Cytotoxicity of tumor necrosis factor-alpha for human umbilical vein endothelial cells. Lab Invest 1989; 61: 62-68.
10. Meyrick B, Christman B, Jesmok G. Effects of recombinant tumor necrosis factor-alpha on cultured pulmonary artery and lung microvascular endothelial monolayers. Am J Pathol 1991; 138: 93-101.
11. Goldblum SE, Sun WL. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol 1990; 258: L57-L67.
12. Campbell WN, Ding X, Goldblum SE. Interleukin-1 alpha and -beta augment pulmonary artery transendothelial albumin flux in vitro. Am J Physiol 1992; 263: L128-L136.
13. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 1991; 138: 447-453.
14. Warren JS, Yabroff KR, Remick DG, et al. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 1989; 84: 1873-1882.
15. Tracey KJ, Lowry SF, Cerami A. Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 1377-1379.
16. Warren JS. Intrapulmonary interleukin 1 mediates acute immune complex alveolitis in the rat. Biochem Biophys Res Commun 1991; 175: 604-610.
17. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 1993; 143: 453-463.
18. Pober JS. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp 1987; 131: 170-184.
19. Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 1993; 71: 76-87.
20. Rollins BJ. Chemokines. Blood 1997; 90: 909-928.
21. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994; 6: 865-873.
22. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
23. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
24. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. CMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel Palade bodies. J Clin Invest 1989; 84: 92-99.
25. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 99: 3-8.
26. Johnson KJ, Ward PA. Acute immunologic pulmonary alveolitis. J Clin Invest 1974; 54: 349-357.
27. Mulligan MS, Varani J, Dame MK, et al. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991; 88: 1396-1406.
28. Mulligan MS, Vaporciyan AA, Warner RL, et al. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immunol 1995; 154: 1350-1363.
29. Mulligan MS, Jones ML, Bolanowski MA, et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993; 150: 5585-5595.
30. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP, Ward PA. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol 1997; 158: 3439-3448.
31. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF-κB) activation in human monocytes. IL-10 and IL-4 suppress cylokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558-9563.
32. Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-κB and preservation of IκBχ by interleukin-10 and interleukin-13. J Clin Invest 1997; 100: 2443-2448.
33. Manna SK, Aggarwal BB. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J Immunol 1998; 161: 2863-2872.
34. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
35. Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997; 159: 3483-3489.
36. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 1995; 154: 3454-3460.
37. Lentsch AB, Czermak BJ, Jordan JA, Ward PA. Regulation of acute lung inflammatory injury by endogenous IL-13. J Immunol 1999; 162: 1071-1076.
38. Gipson TS, Bless NM, Shanley TP, et al. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol 1999; 162: 3653-3662.
39. Lentsch AB, Jordan JA, Czermak BJ, et al. Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 1999; 154: 239-247.